Kidney Cancer
📧 Sign up to get email alerts when something new happens for Kidney Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer [Phase 1, Phase 2]
Investigator-initiated trial evaluating durvalumab and guadecitabine in advanced kidney cancer (Phase 1/2; status: active not recruiting).
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a monoclonal antibody therapy for advanced kidney cancer has completed, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases [Phase 2]
Phase 2 trial comparing denosumab with standard treatment in urothelial cancer patients with bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 trial comparing pazopanib to temsirolimus in poor-risk clear-cell renal cell carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating MEDI0680 (AMP-514) with durvalumab vs nivolumab monotherapy in select advanced malignancies, including…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. [Phase 1]
Phase 1 safety study assessing cG250 antibody labeled with 124-Iodine for diagnosing renal masses has been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial comparing everolimus to sunitinib in non-clear cell renal cell carcinoma was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating a biomarker-driven strategy with nivolumab plus ipilimumab or VEGFR TKI in first-line clear cell metastatic renal c…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Effect of Papaverine on Renal Artery Blood Flow Volume [Phase 4]
Phase 4 trial evaluating the effect of papaverine on renal artery blood flow volume in kidney cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating sunitinib with or without gemcitabine in advanced, unresectable kidney cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients [Phase 2]
Phase 2 trial evaluating SBRT with nivolumab/ipilimumab in metastatic/Stage IV kidney cancer has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer [Phase 3]
Phase 3 trial comparing combination chemotherapy alone versus with radiation therapy in pediatric kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update on allogeneic stem cell transplant for metastatic kidney cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer [Phase 2]
Phase 2 trial evaluating sunitinib as first-line therapy for locally advanced/metastatic papillary renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy in metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Radiosurgery in Treating Patients With Kidney Tumors [NA]
Clinical trial updating results for radiosurgery in kidney tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors [Phase 2]
Phase 2 clinical trial update for DC-CIK immunotherapy in solid tumors; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplant for patients with metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating toripalimab plus axitinib as neoadjuvant therapy for advanced/metastatic non-clear cell renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy [Phase 2]
Phase 2 trial update on allogeneic bone marrow transplantation with less intensive therapy; the study was terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Carfilzomib in Refractory Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 clinical trial update for carfilzomib in refractory renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) [Phase 2]
Phase 2 trial update on sunitinib scheduling in metastatic renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
A combined Phase 1/Phase 2 trial evaluating mycophenolate mofetil with cyclosporine to reduce graft-versus-host disease in patients undergoi…
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of a Tag-7 gene-modified vaccine in locally advanced or metastatic malignant mel…
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer [Phase 2]
Phase 2 trial update for ZD 1839 in stage IV or recurrent kidney cancer has been completed.